Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18452-18457
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18452
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18452
Table 2 Tumor response n (%)
| Unresectable(n = 55) | Recurrent(n = 10) | P value | |
| Complete response | 0 | 2 (20.0) | |
| Partial response | 14 (25.5) | 2 (20.0) | |
| Stable disease | 29 (52.7) | 3 (30.0) | |
| Progressive disease | 10 (18.2) | 2 (20.0) | |
| Not evaluable | 2 (3.6) | 1 (10.0) | |
| Response rate | 25.5% | 40.0% | 0.34 |
| Disease control rate | 78.2% | 70.0% | 0.57 |
- Citation: Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, Yagioka H, Matsubara S, Hanada K, Maguchi H, Kamada H, Hasebe O, Mukai T, Okabe Y, Maetani I, Koike K. Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer. World J Gastroenterol 2014; 20(48): 18452-18457
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18452